FlowTriever - search results
If you're not happy with the results, please do another search
FlowTriever device found to dramatically improve breathing among intermediate-risk acute pulmonary embolism patients
SCVS 2024 saw Zachary AbuRahma, DO, an assistant professor of vascular surgery at West Virginia University and the Charleston Area Medical Center in Charleston,...
FLAME, FLASH and ongoing PEERLESS trials collect ‘compelling’ data for FlowTriever device
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism...
FLASH results demonstrate ‘excellent safety profile’ of the FlowTriever system in full US cohort
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 real-world patients.
This is according to Catalin...
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomized controlled trial (RCT) comparing the outcomes of patients with...
Stryker completes acquisition of Inari Medical
Stryker announced today that it has completed the acquisition of Inari Medical. A press release notes that the addition of Inari brings an established...
How the RevCore and VenaCore thrombectomy catheters combine to broaden treatment approach among advanced...
This advertorial is sponsored by Inari Medical.
For Joseph M. Liechty, MD, a vascular surgeon with Texas Vascular Associates in Plano, Texas, the emergence of...
TCT 2024: PEERLESS trial finds large-bore mechanical thrombectomy superior for intermediate-risk PE
Findings from the first international randomised controlled trial (RCT) to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT)...
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system compared to mechanical...
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...
Behind the procedure: Removing in-stent thrombosis with the RevCore Thrombectomy Catheter
This advertorial is sponsored by Inari Medical.
For patients with in-stent thrombosis (IST), one of the most critical unmet needs has been an effective method...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with high-risk pulmonary embolism (PE) was associated with a significantly lower occurrence...
AVF 2023: FLASH registry suggests ‘favorable safety and effectiveness profile’ in high-risk PE patients
Among 61 high-risk pulmonary embolism (PE) patients followed through to the 30-day visit in the U.S. cohort of the FLASH registry, no mortalities were...
Clinical outcomes of the ClotTriever system in DVT set to be evaluated in RCT
Inari Medical has announced planned enrollment of the DEFIANCE randomized controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
First pulmonary embolism patient enrolled in FLAME study
Inari Medical has announced the enrollment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study....
